Expedia Inc. (NASDAQ:EXPE) [Trend Analysis] surged reacts as active mover, shares a gain 0.71% to traded at $108.79 and the percentage gap among open changing to regular change was 0.91%. Expedia, Inc. released that it has commenced a consent solicitation with respect to a proposed amendment to the indenture governing its 5.95% Senior Notes due 2020, upon the terms and subject to the conditions set forth in the Consent Solicitation Statement, dated September 22, 2016, and the related Letter of Consent.
Expedia is soliciting consents from holders of record of the Notes as of 5:00 P.M., New York City time, on September 21, 2016. Subject to the terms and conditions set forth in the Statement and the related Letter of Consent, Expedia will pay eligible holders who validly deliver their consents on or previous to 5:00 P.M., New York City time, on September 30, 2016, and who do not validly revoke such consents on or previous to the earlier of the Expiration Date or the Effective Time, a cash payment equal to $2.50 per $1,000 aggregate principal amount of Notes consented.
The Consent Fee will only be payable upon and subject to the occurrence of, amidother things, the receipt of the Requisite Consent The firm’s current ratio calculated as 0.60 for the most recent quarter. The firm past twelve months price to sales ratio was 2.19 and price to cash ratio remained 7.25. As far as the returns are concern, the return on equity was recorded as 4.80% and return on investment was 8.90% while its return on asset stayed at 1.30%. The firm has total debt to equity ratio measured as 0.76.
DryShips, Inc. (NASDAQ:DRYS) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 9.36% to close at $0.48 with the total traded volume of 1.53 Million shares. DryShips Inc. (NASDAQ: DRYS) reported that it has sold the 2002 built Panamax drybulk carrier MV Oregon. The vessel MV Oregon, together with the associated bank debt, was sold to an entity controlled by the Firm’s Chairman and CEO, Mr. George Economou.
The vessel was sold for a 10% premium to fair market value, as supported by independent third party broker valuations. Following this transaction, the current outstanding balance under the Firm’s Senior Secured Revolving Facility Contract (“Revolver”) has been surged to $10.8 million. The firm has institutional ownership of 9.60%, while insider ownership included 5.10%. Its price to sales ratio ended at 0.01. DRYS attains analyst recommendation of 3.00 with week performance of -1.80%.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with remains unchanged to $5.83. The share price of ZIOP attracts active investors, as stock price of week volatility recorded 6.01%. The stock is going forward to its 52-week low with 31.01% and lagging behind from its 52-week high price with -60.95%.